Report Detail
COVID-19 Impact on Global Pet Veterinary Drug Market Insights, Forecast to 2026
- RnM4017477 |
- 09 June, 2020 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Pet Veterinary Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pet Veterinary Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pet Veterinary Drug market is segmented into
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application, the Pet Veterinary Drug market is segmented into
Veterinary Hospitals
Veterinary Clinics
Drug Stores
Regional and Country-level Analysis
The Pet Veterinary Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pet Veterinary Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pet Veterinary Drug Market Share Analysis
Pet Veterinary Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Veterinary Drug business, the date to enter into the Pet Veterinary Drug market, Pet Veterinary Drug product introduction, recent developments, etc.
The major vendors covered:
Boehringer Ingelheim International GmbH
Zoetis Animal Healthcare
Bayer AG
Merck Animal Health
Elanco Animal Health Inc.
Virbac Group
Ceva
Dechra Pharmaceuticals Plc
Vetoquinol
Orion Corporation
1 Study Coverage
- 1.1 Pet Veterinary Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Pet Veterinary Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Pet Veterinary Drug Market Size Growth Rate by Type
- 1.4.2 Anti-Infectives
- 1.4.3 Anti-Inflammatory
- 1.4.4 Parasiticides
- 1.4.5 Analgesics
- 1.4.6 Sedatives
- 1.4.7 Others
- 1.5 Market by Application
- 1.5.1 Global Pet Veterinary Drug Market Size Growth Rate by Application
- 1.5.2 Veterinary Hospitals
- 1.5.3 Veterinary Clinics
- 1.5.4 Drug Stores
- 1.6 Coronavirus Disease 2019 (Covid-19): Pet Veterinary Drug Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Pet Veterinary Drug Industry
- 1.6.1.1 Pet Veterinary Drug Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Pet Veterinary Drug Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Pet Veterinary Drug Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Pet Veterinary Drug Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Pet Veterinary Drug Market Size Estimates and Forecasts
- 2.1.1 Global Pet Veterinary Drug Revenue 2015-2026
- 2.1.2 Global Pet Veterinary Drug Sales 2015-2026
- 2.2 Pet Veterinary Drug Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Pet Veterinary Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Pet Veterinary Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pet Veterinary Drug Competitor Landscape by Players
- 3.1 Pet Veterinary Drug Sales by Manufacturers
- 3.1.1 Pet Veterinary Drug Sales by Manufacturers (2015-2020)
- 3.1.2 Pet Veterinary Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 Pet Veterinary Drug Revenue by Manufacturers
- 3.2.1 Pet Veterinary Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 Pet Veterinary Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Pet Veterinary Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Pet Veterinary Drug Revenue in 2019
- 3.2.5 Global Pet Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Pet Veterinary Drug Price by Manufacturers
- 3.4 Pet Veterinary Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Pet Veterinary Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pet Veterinary Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Pet Veterinary Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Pet Veterinary Drug Market Size by Type (2015-2020)
- 4.1.1 Global Pet Veterinary Drug Sales by Type (2015-2020)
- 4.1.2 Global Pet Veterinary Drug Revenue by Type (2015-2020)
- 4.1.3 Pet Veterinary Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Pet Veterinary Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Pet Veterinary Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global Pet Veterinary Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 Pet Veterinary Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Pet Veterinary Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Pet Veterinary Drug Market Size by Application (2015-2020)
- 5.1.1 Global Pet Veterinary Drug Sales by Application (2015-2020)
- 5.1.2 Global Pet Veterinary Drug Revenue by Application (2015-2020)
- 5.1.3 Pet Veterinary Drug Price by Application (2015-2020)
- 5.2 Pet Veterinary Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Pet Veterinary Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global Pet Veterinary Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Pet Veterinary Drug Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Pet Veterinary Drug by Country
- 6.1.1 North America Pet Veterinary Drug Sales by Country
- 6.1.2 North America Pet Veterinary Drug Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Pet Veterinary Drug Market Facts & Figures by Type
- 6.3 North America Pet Veterinary Drug Market Facts & Figures by Application
7 Europe
- 7.1 Europe Pet Veterinary Drug by Country
- 7.1.1 Europe Pet Veterinary Drug Sales by Country
- 7.1.2 Europe Pet Veterinary Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pet Veterinary Drug Market Facts & Figures by Type
- 7.3 Europe Pet Veterinary Drug Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Pet Veterinary Drug by Region
- 8.1.1 Asia Pacific Pet Veterinary Drug Sales by Region
- 8.1.2 Asia Pacific Pet Veterinary Drug Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Pet Veterinary Drug Market Facts & Figures by Type
- 8.3 Asia Pacific Pet Veterinary Drug Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Pet Veterinary Drug by Country
- 9.1.1 Latin America Pet Veterinary Drug Sales by Country
- 9.1.2 Latin America Pet Veterinary Drug Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Pet Veterinary Drug Market Facts & Figures by Type
- 9.3 Central & South America Pet Veterinary Drug Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Pet Veterinary Drug by Country
- 10.1.1 Middle East and Africa Pet Veterinary Drug Sales by Country
- 10.1.2 Middle East and Africa Pet Veterinary Drug Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Pet Veterinary Drug Market Facts & Figures by Type
- 10.3 Middle East and Africa Pet Veterinary Drug Market Facts & Figures by Application
11 Company Profiles
- 11.1 Boehringer Ingelheim International GmbH
- 11.1.1 Boehringer Ingelheim International GmbH Corporation Information
- 11.1.2 Boehringer Ingelheim International GmbH Description, Business Overview and Total Revenue
- 11.1.3 Boehringer Ingelheim International GmbH Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Products Offered
- 11.1.5 Boehringer Ingelheim International GmbH Recent Development
- 11.2 Zoetis Animal Healthcare
- 11.2.1 Zoetis Animal Healthcare Corporation Information
- 11.2.2 Zoetis Animal Healthcare Description, Business Overview and Total Revenue
- 11.2.3 Zoetis Animal Healthcare Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Zoetis Animal Healthcare Pet Veterinary Drug Products Offered
- 11.2.5 Zoetis Animal Healthcare Recent Development
- 11.3 Bayer AG
- 11.3.1 Bayer AG Corporation Information
- 11.3.2 Bayer AG Description, Business Overview and Total Revenue
- 11.3.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bayer AG Pet Veterinary Drug Products Offered
- 11.3.5 Bayer AG Recent Development
- 11.4 Merck Animal Health
- 11.4.1 Merck Animal Health Corporation Information
- 11.4.2 Merck Animal Health Description, Business Overview and Total Revenue
- 11.4.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Merck Animal Health Pet Veterinary Drug Products Offered
- 11.4.5 Merck Animal Health Recent Development
- 11.5 Elanco Animal Health Inc.
- 11.5.1 Elanco Animal Health Inc. Corporation Information
- 11.5.2 Elanco Animal Health Inc. Description, Business Overview and Total Revenue
- 11.5.3 Elanco Animal Health Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Elanco Animal Health Inc. Pet Veterinary Drug Products Offered
- 11.5.5 Elanco Animal Health Inc. Recent Development
- 11.6 Virbac Group
- 11.6.1 Virbac Group Corporation Information
- 11.6.2 Virbac Group Description, Business Overview and Total Revenue
- 11.6.3 Virbac Group Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Virbac Group Pet Veterinary Drug Products Offered
- 11.6.5 Virbac Group Recent Development
- 11.7 Ceva
- 11.7.1 Ceva Corporation Information
- 11.7.2 Ceva Description, Business Overview and Total Revenue
- 11.7.3 Ceva Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Ceva Pet Veterinary Drug Products Offered
- 11.7.5 Ceva Recent Development
- 11.8 Dechra Pharmaceuticals Plc
- 11.8.1 Dechra Pharmaceuticals Plc Corporation Information
- 11.8.2 Dechra Pharmaceuticals Plc Description, Business Overview and Total Revenue
- 11.8.3 Dechra Pharmaceuticals Plc Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Dechra Pharmaceuticals Plc Pet Veterinary Drug Products Offered
- 11.8.5 Dechra Pharmaceuticals Plc Recent Development
- 11.9 Vetoquinol
- 11.9.1 Vetoquinol Corporation Information
- 11.9.2 Vetoquinol Description, Business Overview and Total Revenue
- 11.9.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Vetoquinol Pet Veterinary Drug Products Offered
- 11.9.5 Vetoquinol Recent Development
- 11.10 Orion Corporation
- 11.10.1 Orion Corporation Corporation Information
- 11.10.2 Orion Corporation Description, Business Overview and Total Revenue
- 11.10.3 Orion Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Orion Corporation Pet Veterinary Drug Products Offered
- 11.10.5 Orion Corporation Recent Development
- 11.1 Boehringer Ingelheim International GmbH
- 11.1.1 Boehringer Ingelheim International GmbH Corporation Information
- 11.1.2 Boehringer Ingelheim International GmbH Description, Business Overview and Total Revenue
- 11.1.3 Boehringer Ingelheim International GmbH Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Boehringer Ingelheim International GmbH Pet Veterinary Drug Products Offered
- 11.1.5 Boehringer Ingelheim International GmbH Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Pet Veterinary Drug Market Estimates and Projections by Region
- 12.1.1 Global Pet Veterinary Drug Sales Forecast by Regions 2021-2026
- 12.1.2 Global Pet Veterinary Drug Revenue Forecast by Regions 2021-2026
- 12.2 North America Pet Veterinary Drug Market Size Forecast (2021-2026)
- 12.2.1 North America: Pet Veterinary Drug Sales Forecast (2021-2026)
- 12.2.2 North America: Pet Veterinary Drug Revenue Forecast (2021-2026)
- 12.2.3 North America: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
- 12.3 Europe Pet Veterinary Drug Market Size Forecast (2021-2026)
- 12.3.1 Europe: Pet Veterinary Drug Sales Forecast (2021-2026)
- 12.3.2 Europe: Pet Veterinary Drug Revenue Forecast (2021-2026)
- 12.3.3 Europe: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Pet Veterinary Drug Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Pet Veterinary Drug Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Pet Veterinary Drug Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Pet Veterinary Drug Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Pet Veterinary Drug Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Pet Veterinary Drug Sales Forecast (2021-2026)
- 12.5.2 Latin America: Pet Veterinary Drug Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Pet Veterinary Drug Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Pet Veterinary Drug Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Pet Veterinary Drug Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Pet Veterinary Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Pet Veterinary Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pet Veterinary Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Pet Veterinary Drug. Industry analysis & Market Report on COVID-19 Impact on Global Pet Veterinary Drug is a syndicated market report, published as COVID-19 Impact on Global Pet Veterinary Drug Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Pet Veterinary Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
